TNF Pharmaceuticals 10Q 2018 Q1 Quarterly report | TNFA Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abbreviated, acid, adequate, advantage, advisory, aforementioned, aggressively, allergy, analyst, andin, Andto, Ann, antigen, appointed, appointment, assigned, attention, attestation, auditor, auto, aware, behalf, biological, biotech, broad, building, burden, calendar, Cardinal, Carlyle, cell, cellular, CEPA, CFR, cGMP, Check, cholesterol, clarify, combination, compensatory, compete, compliance, concurrently, contemporaneously, contingent, Conventional, Cosmetic, counsel, counter, damage, David, dedicated, deficiency, delisting, density, departure, deterioration, devote, Diabetic, Diagnostica, difficult, difficulty, diminished, disciplined, disproportionate, disruption, diverse, diversion, diverted, divided, downplayed, downside, drastically, duration, effort, entirety, eventually, exacerbate, exceeded, exempt, explanation, extension, extensive, extracting, extraction, factor, failed, Faulkner, feasibility, firm, Fisher, float, focused, focusing, force, forecast, franchise, Gary, Gleason, globe, golden, good, governmental, grow, harm, hire, hiring, impose, improperly, increasingly, indemnification, indirect, ineffective, intention, ketone, lead, leadership, letter, light, Likewise, lipo, lipoprotein, listed, listing, local, lose, Mainland, marker, mediation, member, met, methodand, misleading, misstatement, multilevel, multiple, network, nonbinding, notified, notifying, nutraceutical, obtain, obtained, obtaining, OEM, open, opportunity, Ourprimary, outsource, overhead, overpayment, oversight, oxidative, par, parachute, path, PCT, pharmaceutical, plaintiff, portfolio, Portland, power, predict, premarket, prevail, prevent, preventable, prevented, privilege, prolonged, promptly, properly, protein, publicly, punitive, qualification, quantitative, quest, ratification, ratify, Rauch, reagent, regulation, reinstatement, relationship, remediate, remediation, replaced, reputation, resignation, resolution, respond, responded, restore, restoring, resubmitted, retaliatory, robust, SA, satisfactorily, scaled, Secretary, sector, shortly, show, single, source, spending, spouse, stability, Stago, standing, Stat, statute, step, stockholder, submission, submit, submitted, sue, suffer, superseded, supervisor, suspend, sustained, tandem, tasked, technician, TheCompany, thereunder, Thermo, thinner, tightening, Tim, track, translate, Troponin, true, uncover, unemployment, unrelated, unused, upgrade, vary, vast, vertically, viability, vigorously, violated, violation, volatile, volatility, withdrew, yield, Yifan

Removed: admitted, aired, assumed, Balancing, base, bulk, campaign, canceling, carry, CE, complex, concentrate, confident, constitute, contra, coordination, Deed, developing, directed, Dispute, DKA, East, efficiency, eliminate, enrolling, Europe, excluding, expenditure, extend, fewer, Frank, Gavin, generating, higher, HIT, import, infomercial, infrastructure, institution, intensive, introduce, Knox, label, labor, lacking, launch, launched, linked, month, Moran, negligible, oncology, outlined, partner, performedin, placement, pledging, positive, PRC, presentation, progressed, promote, reclassified, recover, recovered, recur, referred, remained, renegotiating, revert, Runge, salary, Savy, steady, Strat, systematic, theBalance, Thirty, travel, unit, unsecured, upfront, utilizing, week, weekly, Western, worth

	(1)	Such Quarterly Report on Form 10-Q for the period ended March 31, 2018, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2018, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: July 13, 2018	By:	/s/ Gary M. Rauch
		Gary M. Rauch
		Principal Financial Officer
		Akers Biosciences, Inc.

TNF Pharmaceuticals (TNFA) 10-Q2018 Q1 Quarterly report

Content analysis